|
|
|
|
|
市場調査レポート
生物兵器防衛における市場機会
Market Opportunities in Biodefense Research
|
当商品の販売は、2011年07月19日を持ちまして終了しました。
Biodefense research represents one of the fastest growing markets for life
science suppliers. Billions of dollars are being invested to support basic
research on potential agents of bioterrorism as well as the development of
vaccines, diagnostic tests and therapies to detect and counter the effects of a
bioterrorist attack. In fact, when the budget allocated to the Department of
Health and Human Services as well as the expenditures of other agencies, private
institutions and corporations related to biodefense are considered, the total
market could reach as high as $50 billion within the next few years. Despite
this investment, relatively few tools and techniques are specifically designed
for biodefense research, often leaving researchers to adapt products and
methodologies currently designed for other uses. Looking at the entire market
potential, Market Opportunities in Biodefense Research not only reflects the
experiences and opinions of over 265 scientists who are currently engaged in
biodefense research but also over 235 scientists who plan to conduct biodefense
research within the next year. It provides a thorough analysis of the commercial
opportunities in this market, including the rate at which new researchers are
entering the field and barriers to adoption as well as the most commonly studied
diseases and/or bioterrorism agents, approaches and techniques used and sources
of funding. Respondents also disclosed unmet needs and identified areas where
companies can focus their efforts to capture market share. With the appropriate
research tools, scientists will be able to develop the tools for diagnosis,
treatment, and prevention that will improve the response to future bioterrorist
attacks as well as help deter the ravages of infectious disease outbreaks.
The major objectives of this report are as follows:
- Understand the overall objectives and specific targets of biodefense
research in the U.S.
- Identify predominant tools and techniques employed in biodefense research
to support market segmentation analysis
- Measure the rate of growth of biodefense research as a defined market
within the life science industry
- Describe current obstacles encountered by scientists and technological
developments required to advance biodefense research
- Highlight opportunities for life science suppliers to establish themselves
as credible suppliers of research products to the biodefense market
Table of Contents
Section 1. Analysis and Interpretation of Survey Results
- 1-1 Introduction
- 1-2 Overview
- 1-3 Objectives
- 1-4 Objectives of the U.S. Biodefense Market
- 1- 21 Growth Trends
- 1-22 Market Growth
- 1-25 Growth Segments in the Biodefense Market
- 1-27 Customer Needs and Supplier Opportunities
- 1-28 Turning Obstacles Into Opportunities
- 1-29 New Technologies
- 1-31 Brand Awareness in the Biodefense Market
- 1-32 Life Science Suppliers
- 1-35 Product Development for the Biodefense Market
- 1-37 Positioning in the Biodefense Research
- 1-38 Marketing to Biodefense Researchers
- 1-39 Conclusion
Section 2. Study Methodology and Demographics
- 2-1 Methodology
- 2-5 Demographics
- 2-7 Questionnaire
Section 3. Presentation of Survey Data Research Overview
- 3-1 Current and future plans to conduct biodefense research
- 3-3 Factors that will enable biodefense research to be conducted*
- 3-4 Percentage of lab research that is dedicated to biodefense**
- 3-5 Diseases and/or potential bioterrorism agents studied
- 3-9 Biosafety levels at which research is conducted
- 3-11 Broad applications most closely supported by research
- 3-13 Specific foci of research
- 3-15 Stages that best characterizes research
- 3-17 "Top of mind" suppliers of products used in
biodefense research
Techniques and Technologies
- 3-19 Approaches used
- 3-21 Types of techniques used
- 3-23 Eukaryotic culture techniques used
- 3-25 RNA-based gene expression techniques used
- 3-27 Genome analysis techniques used
- 3-29 Imaging techniques used
- 3-31 Prokaryotic culture techniques used
- 3-33 Protein analysis techniques used
Life Science Suppliers
- 3-35 Top suppliers of products that are not specifically designed for
biodefense applications**
- 3-37 Ease of adapting products that are not specifically designed for
biodefense applications**
- 3-39 Top suppliers of products that are specifically designed for
biodefense applications**
Unmet Needs
- 3-41 Likeliness to evaluate products that are promoted as being
specifically designed for biodefense applications
- 3-43 Areas where suppliers can best support scientists conducting
biodefense research in detection
- 3-45 Areas where suppliers can best support scientists conducting
biodefense research in prevention
- 3-47 Areas where suppliers can best support scientists conducting
biodefense research in treatment
- 3-49 Procedures that would most benefit from the use a commercially
available kit specific to the biological agent studied
- 3-51 Areas in which technological improvements would best help biodefense
research
Resources and Support
- 3-53 Sources of funding for biodefense research
- 3-57 Estimated 2004 lab budgets for biodefense research
- 3-59 Expected changes in lab budgets for biodefense research**
- 3-61 Percentage of 2004 lab budgets for biodefense that is designated to
specific budget items**
- 3-63 Number of researchers in a lab
Associations and Meetings
- 3-65 Membership in professional societies
- 3-69 Attendance at conferences specifically devoted to biodefense research
Challenges and Trends
- 3-73 Challenging bureaucratic roadblocks
- 3-75 Potential bioterrorism threats that should receive more resources to
support its study
- 3-77 Research approaches that will become increasingly important in
enabling breakthroughs
Section 4. Appendices
- 4-1 Cross-Tabulations of Survey Data
- 4-11 Other Publications
- 4-13 About BioInformatics
- 4-15 Our Valued Clients
- * This question was based only on the 236 respondents who plan to conduct
biodefense research within the next year
- ** This question was based only on the 269 respondents who currently
conduct biodefense research
|
 |
